Viewing nowNeurogabapentin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201502967 · Approved 2015.05.18 · Insurance code 622802450
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medication is used to treat peripheral and central neuropathic pain in adults. It is also utilized as an adjunctive therapy for partial seizures in patients with epilepsy, with or without secondary generalized symptoms. Additionally, it is applicable for the treatment of fibromyalgia. This drug aids in alleviating neuropathic pain and managing seizures, improving the patient's quality of life.
Administer the total daily dose of this medicine, pregabalin, orally in 2 divided doses, with or without food. This medicine is excreted mainly by the kidneys; therefore, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose of this medicine may be 150 mg per day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: The starting dose of this medicine may be 150 mg per day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg per day after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: The starting dose of this medicine may be 150 mg per day. Based on the individual patient’s response and tolerability, the dose may be increased to 300 mg per day after 1 week. If necessary, it may then be increased at 7-day intervals to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The starting dose is 75 mg twice daily (150 mg per day); based on efficacy and tolerability, the dose may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Given the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment The clearance of this medicine is directly affected by creatinine clearance; therefore, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) ≥60: starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥30 -<60: starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥15 -<30: starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr), (mL/min) <15: starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: 25-100, single dose b TID = Total daily dose divided into 3 doses BID = Total daily dose divided into 2 doses QD = Once daily a: The total daily dose (mg/day) should be divided as specified under the dosage regimen. b: A supplemental dose is an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (aged 65 years or older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 ~17 years: Use is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so if there are any changes in mood or abnormal signs of behavior during treatment, consult a doctor immediately. Do not take this medication if you have allergies to this drug or certain hereditary conditions such as lactose intolerance. Diabetic patients should be aware that weight gain may occur with this medication, and adjustments to blood sugar control medications may be necessary. If symptoms of angioedema, such as swelling of the face or around the mouth, occur, discontinue use immediately and inform medical personnel. Elderly patients may experience increased dizziness or drowsiness while taking this medication; caution is needed to prevent falls or accidents. This medication may cause visual changes such as blurred vision; if such symptoms occur, consult medical personnel. Withdrawal symptoms such as insomnia, headache, and anxiety may occur upon discontinuation, so do not stop taking the medication abruptly and follow the doctor's instructions. Patients with a history of drug abuse may have an increased risk of misuse with this medication, so use it with special caution. Patients with heart or kidney disease should consult a doctor before taking this medication as dose adjustments may be necessary. Caution is advised when taken with opioid analgesics as it may increase central nervous system depression effects. Avoid use during early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. Breastfeeding may allow the drug to pass into breast milk, so discuss the use of this medication during breastfeeding with medical personnel. Avoid engaging in dangerous activities such as driving and operating machinery until it is confirmed that no dizziness or drowsiness occurs after taking this medication. Overdose may result in confusion, drowsiness, or seizures; if suspected, seek emergency care immediately. This medication should be kept out of reach of children and should not be transferred to another container. If a rash or severe allergic reaction occurs during use, discontinue the medication immediately and inform medical personnel.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 15 to 30 degrees Celsius.
An opaque capsule with a white or slightly yellow powder inside, with a white upper and lower part.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.